CNBC: Bill George: Bresch Should Commit to No Further Price Increases

CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan’s pricing of the EpiPen.